Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Zenflow

Zenflow
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
32 INVESTORS
Description

Operator of a urologic medical device company intended to develop a patient-focused approach to treat the symptoms of benign prostatic hyperplasia (BPH). The company's proprietary implant is composed of superelastic shape-memory material and is deployed through a small, flexible catheter which can allow for less invasive and less painful treatment, enabling patients experiencing BPH symptoms to undergo treatment in a simple procedure in a urologist's office.

Website
Formerly Known As
Torix Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 395 Oyster Point Boulevard
  • Suite 501
  • South San Francisco, CA 94080
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Zenflow’s full profile, request a free trial.

Zenflow Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 000.00 Completed Pre-Clinical Trials
8. Debt - General 27-Nov-2018 000 000.00 Completed Pre-Clinical Trials
7. Early Stage VC (Series A) 08-Dec-2017 000.00 000.00 000.00 Completed Pre-Clinical Trials
6. Accelerator/Incubator 21-Jul-2017 00.000 Completed Pre-Clinical Trials
5. Early Stage VC 01-May-2015 00.000 00.000 Completed Pre-Clinical Trials
4. Accelerator/Incubator 24-Mar-2015 00000 00.000 00.000 Completed Startup
3. Angel (individual) 01-Jan-2015 00.00 00.00 00.00 Completed Startup
2. Grant 01-Jan-2015 $150K Completed Startup
1. Accelerator/Incubator 11-Nov-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Zenflow Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A2 2,174,230 $0.001000 $0.09 $1.1 $1.1 1x $1.1 6.78%
Series A1 78,740 $0.001000 $0.1 $1.27 $1.27 1x $1.27 0.25%
To view this company’s complete Cap Table, request access »

Zenflow Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medi-Tate Venture Capital-Backed Or Akiva, Israel 00 0000 000000000000 0000
00000000 Formerly VC-backed Pleasanton, CA 000 00000 000000&0 00000
00000000 Venture Capital-Backed Dublin, Ireland 00.00 0000000000 0 00.00
000000000 Corporate Backed or Acquired Toronto, Canada 0 00.000 000000000 00.000
To view this company’s complete list of competitors, request access »

Zenflow Investors (32)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cloudstone Capital Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
FundRx Venture Capital Minority 000 0000 000000 0
Medical Technology Venture Partners Venture Capital Minority 000 0000 000000 0
ShangBay Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 32 investors. Get the full list »

Zenflow Executive Team (3)

Name Title Board
Seat
Contact
Info
Nicholas Damiano Co-Founder, Chief Executive Officer & Board Member
Ronald Jabba Chief Operating Officer
Shreya Mehta Co-Founder, Chief Technology Officer & Board Member

Zenflow Board Members (5)

Name Representing Role Since Contact
Info
Bryan Kim The Invus Group Board Member 000 0000
Nicholas Damiano Zenflow Co-Founder, Chief Executive Officer & Board Member 000 0000
Radu Cautis Medical Technology Venture Partners Board Member 000 0000
Robert Weisskoff Ph.D F-Prime Capital Partners Board Member 000 0000
Shreya Mehta Zenflow Co-Founder, Chief Technology Officer & Board Member 000 0000